English español

Repositorio de la Universidad de Oviedo. > Producción Bibliográfica de UniOvi: RECOPILA > Artículos >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10651/44757

Title: USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer
Author(s): Martínez Fraile, Julia
Manchado, Eusebio
Lujambio, Amaia
Quesada Fernández, Víctor
Campos Iglesias, Diana
Webb, Thomas R.
Lowe, Scott W.
López Otín, Carlos
Pérez Freije, José María
Issue date: 2017
Publisher version: http://dx.doi.org/10.1074/jbc.M116.762757
Citation: Journal Of Biological Chemistry, 292(10), p. 4164-4175 (2017); doi:10.1074/jbc.M116.762757
Format extent: p. 4164-4175
URI: http://hdl.handle.net/10651/44757
ISSN: 0021-9258
Sponsored: Principado de Asturias, Spain; National Institutes of Health Grant [CA140474]; American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital; Ministerio de Economia y Competitividad; Instituto de Salud Carlos III (CIBERONC, Plan Feder); Fundacion EDP
This work was supported by grants from the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (CIBERONC, Plan Feder), Fundacion EDP, and Principado de Asturias, Spain. The discovery and synthesis of sudemycin D1 and D6 were supported in part by National Institutes of Health Grant CA140474, the American Lebanese Syrian Associated Charities (ALSAC), and St. Jude Children's Research Hospital. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Appears in Collections:Artículos

Files in This Item:

There are no files associated with this item.

Exportar a Mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Base de Datos de Autoridades Biblioteca Universitaria Consultas / Sugerencias